This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A prospective, randomised multi-centre phase II st...
Clinical trial

A prospective, randomised multi-centre phase II study evaluating the adjuvant, neoadjuvant or palliative treatment with tamoxifen +/- GnRH analogue versus aromatase inhibitor + GnRH analogue in male breast cancer patients.

Read time: 1 mins
Last updated:17th Jan 2012
To determine the estradiol suppression between the three treatment arms after three months.
Category Value
Study start date 2012-01-17

View full details